(Q36300076)

13 August 2017

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. (English)

1 reference

13 August 2017

0 references

4

Hans-Peter Hartung

1 reference

13 August 2017

12

Ludwig Kappos

1 reference

13 August 2017

8

Frederik Barkhof

1 reference

13 August 2017

14

Alberto Ascherio

1 reference

13 August 2017

5

David H Miller

1 reference

13 August 2017

1

Kassandra L Munger

1 reference

13 August 2017

2

Kathryn C Fitzgerald

2 references

ORCID Public Data File 2021

13 August 2017

3

Mark S Freedman

1 reference

13 August 2017

6

Xavier Montalbán

1 reference

13 August 2017

7

Gilles Edan

1 reference

13 August 2017

11

Rupert Sandbrink

1 reference

13 August 2017

13

Christoph Pohl

1 reference

13 August 2017

9

Gustavo Suarez

1 reference

13 August 2017

10

Ernst-Wilhelm Radue

1 reference

PMC publication ID

4653109

13 August 2017

language of work or name

English

0 references

publication date

9 October 2015

1 reference

13 August 2017

1 reference

13 August 2017

85

1 reference

13 August 2017

19

1 reference

13 August 2017

1694-1701

1 reference

EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

The initiation and prevention of multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Smoking and disease progression in multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Smoke exposure increases the risk for multiple sclerosis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Cigarette smoking and the progression of multiple sclerosis.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4653109

Smoking is a risk factor for multiple sclerosis

22 September 2018

1 reference

12 December 2020

Cotinine concentrations in semen, urine, and blood of smokers and nonsmokers

1 reference

12 December 2020

Cigarette smoking and progression in multiple sclerosis

1 reference

12 December 2020

Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity

1 reference

12 December 2020

10.1212/WNL.0000000000002099

Identifiers

DOI

1 reference

13 August 2017

1 reference

PMC publication ID

4653109

13 August 2017

PubMed publication ID

26453645

1 reference

PMC publication ID

4653109